Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Biochimica Et Biophysica Acta|October 4, 2014
Quantitative analysis of a phosphoproteome readily altered by the protein kinase CK2 inhibitor quinalizarin in HEK-293T cellsCinzia Franchin, Luca Cesaro, Mauro Salvi, et al.
The FEBS Journal|November 3, 2018
The Golgi 'casein kinase' Fam20C is a genuine 'phosvitin kinase' and phosphorylates polyserine stretches devoid of the canonical consensusGiorgio Cozza, Enrico Moro, Miles Black, et al.
Cellular and Molecular Life Sciences : CMLS|March 16, 2022
Targeting the E1 ubiquitin-activating enzyme (UBA1) improves elexacaftor/tezacaftor/ivacaftor efficacy towards F508del and rare misfolded CFTR mutantsChristian Borgo, Claudio D'Amore, Valeria Capurro, et al.
Cells|January 22, 2021
Contribution of the CK2 Catalytic Isoforms α and α' to the Glycolytic Phenotype of Tumor CellsFrancesca Zonta, Christian Borgo, Camila Paz Quezada Meza, et al.
International Journal of Molecular Sciences|November 30, 2019
Protein Kinase CK2 Subunits Differentially Perturb the Adhesion and Migration of GN11 Cells: A Model of Immature Migrating NeuronsAntonella Lettieri, Christian Borgo, Luca Zanieri, et al.
European Journal of Medicinal Chemistry|February 6, 2021
Comparing the efficacy and selectivity of Ck2 inhibitors. A phosphoproteomics approachChristian Borgo, Luca Cesaro, Tsuyoshi Hirota, et al.
Scientific Reports|February 18, 2017
Generation and quantitative proteomics analysis of CK2α/α'(-/-) cellsChristian Borgo, Cinzia Franchin, Stefano Scalco, et al.
Open Biology|February 22, 2023
Analysis of the phosphoproteome of CK2α(-/-)/Δα' C2C12 myoblasts compared to the wild-type cellsChristian Borgo, Luca Cesaro, Tsuyoshi Hirota, et al.
Biochimica Et Biophysica Acta|November 6, 2007
Glycyrrhetinic acid as inhibitor or amplifier of permeability transition in rat heart mitochondriaValentina Battaglia, Anna Maria Brunati, Cristina Fiore, et al.
The Biochemical Journal|September 10, 2015
Design, validation and efficacy of bisubstrate inhibitors specifically affecting ecto-CK2 kinase activityGiorgio Cozza, Sofia Zanin, Stefania Sarno, et al.
Pageof 8